Mamas Mamas, Ruben de Winter, and Paul Knaapen discuss the results of the PROCTOR trial, which explored native vessel versus ...

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

Sahil Parikh and David Cohen discuss the late-breaking trials from day 3.